Camp4 Therapeutics (CAMP) Free Cash Flow (2023 - 2026)

Camp4 Therapeutics has reported Free Cash Flow for 4 years, with the latest figure at -$11.0 million in Q1 2026.

• Quarterly Free Cash Flow rose 23.13% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.5 million (up 45.86% YoY) and the FY2025 annual result came in at -$29.8 million, up 35.15% from the prior year.
• Free Cash Flow fell to -$11.0 million in Q1 2026 per CAMP's latest filing, from $6.2 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $6.2 million in Q4 2025 and troughed at -$14.3 million in Q1 2025.
• A 4-year average of -$9.9 million and a median of -$11.2 million in 2024 frame the typical range for Free Cash Flow.
• The widest YoY moves for Free Cash Flow: up 154.08% in 2025, down 26.49% in 2025.
• Over 4 years, Free Cash Flow stood at -$12.4 million in 2023, then advanced by 6.88% to -$11.6 million in 2024, then soared by 154.08% to $6.2 million in 2025, then tumbled by 275.78% to -$11.0 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$11.0 million, $6.2 million, and -$11.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.